Issue navigation
Volume 5, Issue 3, September 2023
Editorial
Editorial: DNA repair and nucleic acid therapeutics in cancer
NAR Cancer, Volume 5, Issue 3, September 2023, zcad044, https://doi.org/10.1093/narcan/zcad044
DNA Repair and Nucleic Acids Therapeutics in Cancer
Replication DNA polymerases, genome instability and cancer therapies
NAR Cancer, Volume 5, Issue 3, September 2023, zcad033, https://doi.org/10.1093/narcan/zcad033
Articles
TP53 germline pathogenic variants in modern humans were likely originated during recent human history
NAR Cancer, Volume 5, Issue 3, September 2023, zcad025, https://doi.org/10.1093/narcan/zcad025
The 3D chromatin landscape of rhabdomyosarcoma
NAR Cancer, Volume 5, Issue 3, September 2023, zcad028, https://doi.org/10.1093/narcan/zcad028
Synthetic lethal interaction between WEE1 and PKMYT1 is a target for multiple low-dose treatment of high-grade serous ovarian carcinoma
NAR Cancer, Volume 5, Issue 3, September 2023, zcad029, https://doi.org/10.1093/narcan/zcad029
DNA mismatch repair in cancer immunotherapy
NAR Cancer, Volume 5, Issue 3, September 2023, zcad031, https://doi.org/10.1093/narcan/zcad031
DICER1 platform domain missense variants inhibit miRNA biogenesis and lead to tumor susceptibility
NAR Cancer, Volume 5, Issue 3, September 2023, zcad030, https://doi.org/10.1093/narcan/zcad030
PKM2 dictates the poised chromatin state of PFKFB3 promoter to enhance breast cancer progression
NAR Cancer, Volume 5, Issue 3, September 2023, zcad032, https://doi.org/10.1093/narcan/zcad032
Single-cell multi-gene identification of somatic mutations and gene rearrangements in cancer
NAR Cancer, Volume 5, Issue 3, September 2023, zcad034, https://doi.org/10.1093/narcan/zcad034
Dysfunction of ubiquitin protein ligase MYCBP2 leads to cell resilience in human breast cancers
NAR Cancer, Volume 5, Issue 3, September 2023, zcad036, https://doi.org/10.1093/narcan/zcad036
Effectively utilizing publicly available databases for cancer target evaluation
NAR Cancer, Volume 5, Issue 3, September 2023, zcad035, https://doi.org/10.1093/narcan/zcad035
Heterogeneity in the gene regulatory landscape of leiomyosarcoma
NAR Cancer, Volume 5, Issue 3, September 2023, zcad037, https://doi.org/10.1093/narcan/zcad037
An integrated genomic approach identifies follistatin as a target of the p63-epidermal growth factor receptor oncogenic network in head and neck squamous cell carcinoma
NAR Cancer, Volume 5, Issue 3, September 2023, zcad038, https://doi.org/10.1093/narcan/zcad038
The transcriptional landscape of endogenous retroelements delineates esophageal adenocarcinoma subtypes
NAR Cancer, Volume 5, Issue 3, September 2023, zcad040, https://doi.org/10.1093/narcan/zcad040
CDK2 regulates collapsed replication fork repair in CCNE1-amplified ovarian cancer cells via homologous recombination
NAR Cancer, Volume 5, Issue 3, September 2023, zcad039, https://doi.org/10.1093/narcan/zcad039
Circular stable intronic RNAs possess distinct biological features and are deregulated in bladder cancer
NAR Cancer, Volume 5, Issue 3, September 2023, zcad041, https://doi.org/10.1093/narcan/zcad041
Alkylation of nucleobases by 2-chloro-N,N-diethylethanamine hydrochloride (CDEAH) sensitizes PARP1-deficient tumors
NAR Cancer, Volume 5, Issue 3, September 2023, zcad042, https://doi.org/10.1093/narcan/zcad042
The dynamic process of covalent and non-covalent PARylation in the maintenance of genome integrity: a focus on PARP inhibitors
NAR Cancer, Volume 5, Issue 3, September 2023, zcad043, https://doi.org/10.1093/narcan/zcad043
Co-evolution of AR gene copy number and structural complexity in endocrine therapy resistant prostate cancer
NAR Cancer, Volume 5, Issue 3, September 2023, zcad045, https://doi.org/10.1093/narcan/zcad045
IQGAP1 mediates the communication between the nucleus and the mitochondria via NDUFS4 alternative splicing
NAR Cancer, Volume 5, Issue 3, September 2023, zcad046, https://doi.org/10.1093/narcan/zcad046
Inhibition of nonsense-mediated mRNA decay reduces the tumorigenicity of human fibrosarcoma cells
NAR Cancer, Volume 5, Issue 3, September 2023, zcad048, https://doi.org/10.1093/narcan/zcad048
Large-scale phenogenomic analysis of human cancers uncovers frequent alterations affecting SMC5/6 complex components in breast cancer
NAR Cancer, Volume 5, Issue 3, September 2023, zcad047, https://doi.org/10.1093/narcan/zcad047
INHAT subunit SET/TAF-Iβ regulates PRC1-independent H2AK119 mono-ubiquitination via E3 ligase MIB1 in colon cancer
NAR Cancer, Volume 5, Issue 3, September 2023, zcad050, https://doi.org/10.1093/narcan/zcad050
Comprehensive and realistic simulation of tumour genomic sequencing data
NAR Cancer, Volume 5, Issue 3, September 2023, zcad051, https://doi.org/10.1093/narcan/zcad051
Specificity of cancer-related chromosomal translocations is linked to proximity after the DNA double-strand break and subsequent selection
NAR Cancer, Volume 5, Issue 3, September 2023, zcad049, https://doi.org/10.1093/narcan/zcad049
